Alexandria Forbes Net Worth
Alexandria Forbes biography
Dr. Alexandria Forbes, Ph.D. is President, Chief Executive Officer, Director of the Company since March 2015. Prior to joining MeiraGTx, Dr. Forbes served as Senior Vice President of Commercial Operations at Kadmon Holdings, Inc., a biopharmaceutical company, from September 2013 to April 2015, and currently serves as a member of its board of directors. Effective upon the effectiveness of the registration statement of which this prospectus forms a part, Dr. Forbes will resign from the board of directors of Kadmon Holdings, Inc. A subsidiary of Kadmon Holdings, Inc. is a holder of more than 5% of our outstanding shares. Prior to Kadmon Holdings, Inc., Dr. Forbes spent eleven years as a healthcare investor at Sivik Global Healthcare (formerly Argus Partners), a healthcare hedge fund, from August 2001 to November 2008, and at Meadowvale Asset Management, a healthcare hedge fund, from January 2010 to June 2012. Before entering the hedge fund industry, Dr. Forbes was a Human Frontiers/Howard Hughes postdoctoral fellow at the Skirball Institute of Biomolecular Medicine at NYU Langone Medical Center from March 1997 to September 2000. Prior to this, Dr. Forbes was a research fellow at Duke University, and also at the Carnegie Institute at Johns Hopkins University. Dr. Forbes received an M.A. in Natural Sciences from Cambridge University and a Ph.D. in Molecular Genetics from Oxford University.
What is the salary of Alexandria Forbes?
As the President, Chief Executive Officer, and Director of MeiraGTx Plc, the total compensation of Alexandria Forbes at MeiraGTx Plc is $1,122,170. There are no executives at MeiraGTx Plc getting paid more.
How old is Alexandria Forbes?
Alexandria Forbes is 53, he’s been the President, Chief Executive Officer, and Director of MeiraGTx Plc since 2015. There are 7 older and 3 younger executives at MeiraGTx Plc. The oldest executive at MeiraGTx Holdings Plc is Arnold Levine, 78, who is the Independent Director.
What’s Alexandria Forbes’s mailing address?
Alexandria’s mailing address filed with the SEC is C/O KADMON HOLDINGS, INC., 450 E. 29TH STREET, NEW YORK, NY, 10016.
Insider trading at MeiraGTx Plc
Over the last few years, insiders at MeiraGTx Plc have traded over $0 worth of MeiraGTx Plc stock and bought 3,113,212 units worth $48,763,809 . The most active insider traders include Advisors Llcperceptive Life…, Life Sciences Master Fund L…, and Joel S Marcus. On average, MeiraGTx Plc executives and independent directors trade stock every 143 days with the average trade being worth of $15,182,092. The most recent stock trade was executed by Advisors Llcperceptive Life… on 12 August 2019, trading 425,531 units of MGTX stock currently worth $9,999,979.
What does MeiraGTx Plc do?
MeiraGTx Holdings Plc is a clinical-stage biotech company, which engages in the development of novel gene therapy treatments. It operates through the United States and United Kingdom geographical segments. Its pipeline includes AAV-CNGB3, AAV-CNGA3, AAV-RPE65, AAV-RPGR, AAV-AQP1, and AAV-UPF1. The company was founded on March 20, 2015 and is headquartered in New York, NY.
What does MeiraGTx Plc’s logo look like?
MeiraGTx Plc executives and stock owners
MeiraGTx Plc executives and other stock owners filed with the SEC include:
- Alexandria Forbes, President, Chief Executive Officer, Director
- Richard Giroux, Chief Financial Officer, Chief Operating Officer
- Stuart Naylor, Chief Development Officer
- Gregory Moss, Independent Director
- Neil Mendoza, Independent Director
- Joel Marcus, Independent Director
- Arnold Levine, Independent Director
- Martin Indyk, Director
- Ellen Hukkelhoven, Independent Director
- Thomas Shenk, Director
- Nicole Seligman, Director
- Keith Harris, Independent Chairman of the Board
- Advisors Llcperceptive Life…,
- Katherine Breedis, Chief Financial Officer
- Life Sciences Master Fund L…,
- Bruce Gottlieb, General Counsel
- Advisors Llcedelman Joseph …,
